Please use this identifier to cite or link to this item:
https://doi.org/10.15252/emmm.201911908
Title: | Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity | Authors: | Koch, C. Kuske, A. Joosse, S.A. Yigit, G. Sflomos, G. Thaler, S. Smit, D.J. Werner, S. Borgmann, K. Gärtner, S. Mossahebi Mohammadi, P. Battista, L. Cayrefourcq, L. Altmüller, J. Salinas-Riester, G. Raithatha, K. Zibat, A. Goy, Y. Ott, L. Bartkowiak, K. Tan, T.Z. Zhou, Q. Speicher, M.R. Müller, V. Gorges, T.M. Jücker, M. Thiery, J.-P. Brisken, C. Riethdorf, S. Alix-Panabières, C. Pantel, K. |
Keywords: | breast cancer circulating tumor cells functional studies liquid biopsy metastasis |
Issue Date: | 2020 | Publisher: | Blackwell Publishing Ltd | Citation: | Koch, C., Kuske, A., Joosse, S.A., Yigit, G., Sflomos, G., Thaler, S., Smit, D.J., Werner, S., Borgmann, K., Gärtner, S., Mossahebi Mohammadi, P., Battista, L., Cayrefourcq, L., Altmüller, J., Salinas-Riester, G., Raithatha, K., Zibat, A., Goy, Y., Ott, L., Bartkowiak, K., Tan, T.Z., Zhou, Q., Speicher, M.R., Müller, V., Gorges, T.M., Jücker, M., Thiery, J.-P., Brisken, C., Riethdorf, S., Alix-Panabières, C., Pantel, K. (2020). Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO Molecular Medicine 12 (9) : e11908. ScholarBank@NUS Repository. https://doi.org/10.15252/emmm.201911908 | Rights: | Attribution 4.0 International | Abstract: | Functional studies giving insight into the biology of circulating tumor cells (CTCs) remain scarce due to the low frequency of CTCs and lack of appropriate models. Here, we describe the characterization of a novel CTC-derived breast cancer cell line, designated CTC-ITB-01, established from a patient with metastatic estrogen receptor-positive (ER+) breast cancer, resistant to endocrine therapy. CTC-ITB-01 remained ER+ in culture, and copy number alteration (CNA) profiling showed high concordance between CTC-ITB-01 and CTCs originally present in the patient with cancer at the time point of blood draw. RNA-sequencing data indicate that CTC-ITB-01 has a predominantly epithelial expression signature. Primary tumor and metastasis formation in an intraductal PDX mouse model mirrored the clinical progression of ER+ breast cancer. Downstream ER signaling was constitutively active in CTC-ITB-01 independent of ligand availability, and the CDK4/6 inhibitor Palbociclib strongly inhibited CTC-ITB-01 growth. Thus, we established a functional model that opens a new avenue to study CTC biology. © 2020 The Authors. Published under the terms of the CC BY 4.0 license | Source Title: | EMBO Molecular Medicine | URI: | https://scholarbank.nus.edu.sg/handle/10635/198157 | ISSN: | 1757-4676 | DOI: | 10.15252/emmm.201911908 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_15252_emmm_201911908.pdf | 3.53 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License